NEWS: Medical Research Group launches new website
PROJECTS: We are involved in current, future & consultancy projects,
learn more...
PUBLICATIONS:
Browse
some of our published works
INFO: Need more information? Search
HILO
or
NICE
Home
Careers
Press
Contact
Medical Research UK
About Us
Projects
Publications
Education & Careers
Contact Us
Search
PubMed
Google
Information
HILO
NICE
Invited Presentations
The Epidemiology of DVT - WHO Report, Geneva (1991) Cohen AT and Kakkar VV.
"Risk factors for bleeding in surgery" at Thromboprophylaxis in Surgery, TRI, London 1992.
"Thrombin inhibitor and coronary angioplasty - Results of an international trial" at XIV Congress of the International Society for Thrombosis and Haemostasis, New York, 1993.
"The changing pattern of venous thromboembolic disease." International Society Thrombosis. Bilbao, Spain, June 1994.
"Risk factors for perioperative bleeding in patients receiving heparin prophylaxis." Surgical Research Society. Glasgow, July 1994.
"L
ow molecular weight heparin in vascular surgery". Thrombosis Update Symposium. Oslo March 1995.
"
Fragmin in the prevention of recurrent thrombosis”. Thrombosis Update Symposium. Oslo March 1995.
"Ultra Low Molecular Weight Heparins”. International Union of Angiology. Sydney, December 1995.
"Use of L
ow Molecular Weight Heparins in Cardiovascular Disease”. International Union of Angiology. Sydney, December 1995.
"Essential Statistics - with examples”.
The Institute of Orthopaedics, University College London. London, March 1996.
"Heparin induced Osteoporosis”.
The King's Bone Group, KCSMD, University London. London, May 1996.
"Low molecular weight heparin for the treatment of venous thromboembolism
". Best Clinical Practice Meeting, KCSMD, University London. London, July 1996.
"A review of 6,748 venograms
". ANZ Angiology Meeting, Adelaide, October 1996.
"Severity of DVT and development of Post-phlebitic syndrome”.
ANZ Angiology Meeting, Adelaide, October 1996.
"HRT and venous thromboembolism - epidemiology and basic concepts” RPMS Institute of Obstetrics and Gynaecology, University of London, March 1997.
"Perioperative adverse cardiac outcomes - epidemiology and therapeutic approaches”. European Society of Anaesthesiology, Lausanne, Switzerland, May 1997.
"Blood coagulation and the sex hormones - What to tell the patient?”. British Menopause Society Annual Meeting, Birmingham University, UK, June 1997.
"Risk assessment models in thromboprophylaxis for orthopaedic surgery”. Thrombosis Forum. Barcelona, Spain, 26 June 1998.
"Management of the non-surgical moderate- and high-risk patient”. The International Society of Haematology - European Haematology Association Combined Congress. Amsterdam, The Netherlands. 4 July 1998.
"Risk assessment models in thromboprophylaxis for orthopaedic surgery”. XIII World Congress of the International Union of Phlebology. Sydney, Australia. 8 September 1998.
5.6.21"Prophylaxis in medical patients”. XIII World Congress of the International Union of Phlebology. Sydney, Australia. 8 September 1998.
"Efficacy and bleeding risk of low molecular weight heparin in the prophylaxis of deep vein thrombosis after orthopaedic/trauma surgery”. 11
th
Reunion Nationale, Groupe d’Etude Thrombose et Hemostase en Chirurgie de l’Appareil Loco-motor (GETHCAM), Lyon, France, 9
th
October 1998.
“The Management of Venous Thromboembolism” SE Thames SpR
training, KCH. 9 December 1998.
“DVT prophylaxis with LMWH in hospital patients”. Spanish National Congress of Vascular Surgery, Almeria, Spain. 4 June 1999.